Lupin receives tentative approval from U.S. FDA for ivacaftor tablets

8 June 2022 - Lupin today announced that it has received tentative approval from the United States FDA for its ...

Read more →

Sun Pharma announces US FDA approval for generic mesalamine extended release capsules

12 May 2022 - Sun Pharmaceutical Industries today announced that it has received final approval from U.S. FDA for its ...

Read more →

Eton Pharmaceuticals announces FDA approval of cysteine hydrochloride injection

11 April 2022 - Eton Pharmaceuticals today announced that it has received final approval from the U.S. FDA for its cysteine ...

Read more →

Amphastar receives FDA approval for ganirelix acetate injection

8 April 2022 - Amphastar Pharmaceuticals announced that the U.S. FDA has approved the Company's abbreviated new drug application for ganirelix ...

Read more →

Curium announces FDA approval of a generic version of DaTscan (Ioflupane I 123 injection) in the U.S.

5 April 2022 - Curium announced today that its generic version of DaTscan (Ioflupane I 123 injection) was approved on 30 ...

Read more →

New Australian agency to accelerate genomic research and drive innovation in health care

21 March 2022 - Genomics advances will help develop revolutionary treatments for some of our biggest health challenges, including diagnosing ...

Read more →

FDA approves first generic of Symbicort to treat asthma and COPD

15 March 2022 - Agency supports development of complex generic drug-device combination product to improve competition and access to more affordable ...

Read more →

Teva announces launch of a first generic version of Revlimid (lenalidomide capsules) in the U.S.

7 March 2022 - Teva Pharmaceuticals announced today the launch of a first generic version of Revlimid (lenalidomide capsules), in 5 ...

Read more →

Approved first generic for Apokyn injection cartridges requires separately packaged pen

24 February 2022 - The U.S. FDA has approved the first generic of Apokyn (apomorphine hydrochloride injection) drug cartridges to ...

Read more →

Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine

18 February 2022 - Cost savings from Lenalidomide Sandoz can expand treatment options for patients with haemato-oncology conditions. ...

Read more →

Office of Generic Drugs 2021 Annual Report

14 February 2022 - Ensuring high quality, affordable generic drugs are available to the American public. ...

Read more →

FDA approves first generic of Restasis

2 February 2022 - The U.S. FDA has approved the first generic of Restasis (cyclosporin ophthalmic emulsion) 0.05% single use vials ...

Read more →

Billionaire Mark Cuban opens online pharmacy to provide affordable generic drugs

20 January 2022 - Billionaire investor Mark Cuban launched an online pharmacy Thursday that offers more than 100 generic drugs at ...

Read more →

FDA’s Woodcock says agency has resumed normal review pace for biosimilars, generics

9 November 2021 - Janet Woodcock, MD, acting commissioner of the FDA, delivered an upbeat report on biosimilars and generics progress ...

Read more →

The hurried push by Congress to address drug costs shouldn’t undermine the vast savings from generics and biosimilars

6 November 2021 - Americans rightfully expect Congress to address the ever increasing prices of brand-name prescription drugs. ...

Read more →